Cell Source, Inc.
General ticker "CLCS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $16.5M (TTM average)
Cell Source, Inc. follows the US Stock Market performance with the rate: 14.2%.
Estimated limits based on current volatility of 6.6%: low 0.27$, high 0.31$
Factors to consider:
- Earnings expected soon, date: 2025-06-23 bmo
Short-term CLCS quotes
Long-term CLCS plot
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $4.02MM | $4.18MM | $4.33MM |
| Operating Income | $-4.02MM | $-4.18MM | $-4.33MM |
| Non-Operating Income | $-1.45MM | $-0.99MM | $-1.00MM |
| Interest Expense | $1.36MM | $0.17MM | $0.67MM |
| R&D Expense | $1.32MM | $2.00MM | $1.58MM |
| Income(Loss) | $-5.47MM | $-5.17MM | $-5.32MM |
| Profit(Loss)* | $-6.83MM | $-992,419.18MM | $-5.32MM |
| Stockholders Equity | $-9.83MM | $-12.63MM | $-15.61MM |
| Assets | $0.31MM | $0.41MM | $0.20MM |
| Operating Cash Flow | $-3.38MM | $-3.14MM | $-2.35MM |
| Financing Cash Flow | $3.23MM | $3.27MM | $2.15MM |
| Earnings Per Share** | $-0.21 | $-28,488.18 | $-0.14 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.